Skip to content
healthcare.dev

lenalidomide

NDC 69097-385, lenalidomide, capsule, from Cipla USA Inc..

Product NDC
69097-385
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210435
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-385 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LENALIDOMIDE25 mg/1

Pharmacologic classes

Thalidomide Analog [EPC]

Package NDCNDC-11Package
69097-385-816909703858121 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ba2a07fd-ca60-40bc-b79b-9caf81900fa3

Use it

Look up 69097-385 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-385 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-385. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.